David Roman
Stock Analyst at Goldman Sachs
(3.40)
# 2,341
Out of 4,520 analysts
245
Total ratings
50.4%
Success rate
4.8%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BAX Baxter International | Rated: Hold | $17 → $21 | $22.61 | -7.12% | 20 | Jul 15, 2026 | |
| BBNX Beta Bionics | Rated: Buy | $17 → $19 | $17.29 | +9.89% | 7 | Jul 15, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $71 → $57 | $44.03 | +29.46% | 11 | Jul 14, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Hold | $21 → $16 | $17.08 | -6.32% | 7 | Jul 14, 2026 | |
| BLCO Bausch + Lomb | Maintained: Hold | $19 → $21 | $16.26 | +29.15% | 4 | Jul 14, 2026 | |
| OMDA Omada Health | Maintained: Buy | $25 → $29 | $23.70 | +22.36% | 8 | Jul 14, 2026 | |
| MOBI Mobia Medical | Reiterated: Buy | $31 | $12.15 | +155.14% | 2 | Jul 14, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $95 → $98 | $85.73 | +14.31% | 18 | Jun 15, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $558 | $345.42 | +61.54% | 21 | Jun 15, 2026 | |
| MDT Medtronic | Maintained: Hold | $84 → $83 | $83.20 | -0.24% | 12 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $24 | $16.93 | +41.76% | 2 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 → $113 | $100.68 | +12.24% | 13 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $89 → $88 | $97.67 | -9.90% | 5 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $73 → $61 | $71.71 | -14.94% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $237 → $205 | $164.06 | +24.95% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $8 | $9.43 | -15.16% | 8 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $153 | $156.83 | -2.44% | 4 | May 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $76.65 | +4.37% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $28 → $24 | $21.52 | +11.52% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $21.59 | -7.36% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $72 | $80.70 | -10.78% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $50 | $39.79 | +25.66% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $54 → $66 | $81.31 | -18.83% | 2 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $16 | $11.66 | +37.22% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $357 → $361 | $319.87 | +12.86% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $147 | $110.88 | +32.58% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $63.07 | - | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $192 → $167 | $158.17 | +5.58% | 5 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 → $17 | $24.42 | -30.38% | 7 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $93 → $88 | $91.12 | -3.42% | 8 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $39 → $29 | $77.86 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $21 | $77.00 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $103 | $108.35 | n/a | 1 | Nov 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $44 → $15 | $6.85 | n/a | 2 | Aug 30, 2012 |
Baxter International
Jul 15, 2026
Rated: Hold
Price Target: $17 → $21
Current: $22.61
Upside: -7.12%
Beta Bionics
Jul 15, 2026
Rated: Buy
Price Target: $17 → $19
Current: $17.29
Upside: +9.89%
Boston Scientific
Jul 14, 2026
Maintained: Buy
Price Target: $71 → $57
Current: $44.03
Upside: +29.46%
Tandem Diabetes Care
Jul 14, 2026
Maintained: Hold
Price Target: $21 → $16
Current: $17.08
Upside: -6.32%
Bausch + Lomb
Jul 14, 2026
Maintained: Hold
Price Target: $19 → $21
Current: $16.26
Upside: +29.15%
Omada Health
Jul 14, 2026
Maintained: Buy
Price Target: $25 → $29
Current: $23.70
Upside: +22.36%
Mobia Medical
Jul 14, 2026
Reiterated: Buy
Price Target: $31
Current: $12.15
Upside: +155.14%
Edwards Lifesciences
Jun 15, 2026
Maintained: Buy
Price Target: $95 → $98
Current: $85.73
Upside: +14.31%
Intuitive Surgical
Jun 15, 2026
Reiterated: Buy
Price Target: $558
Current: $345.42
Upside: +61.54%
Medtronic
Jun 4, 2026
Maintained: Hold
Price Target: $84 → $83
Current: $83.20
Upside: -0.24%
Jun 3, 2026
Maintained: Buy
Price Target: $14 → $24
Current: $16.93
Upside: +41.76%
May 31, 2026
Maintained: Buy
Price Target: $121 → $113
Current: $100.68
Upside: +12.24%
May 29, 2026
Maintained: Sell
Price Target: $89 → $88
Current: $97.67
Upside: -9.90%
May 27, 2026
Maintained: Sell
Price Target: $73 → $61
Current: $71.71
Upside: -14.94%
May 27, 2026
Maintained: Buy
Price Target: $237 → $205
Current: $164.06
Upside: +24.95%
May 27, 2026
Maintained: Buy
Price Target: $7 → $8
Current: $9.43
Upside: -15.16%
May 25, 2026
Reiterated: Buy
Price Target: $153
Current: $156.83
Upside: -2.44%
May 15, 2026
Maintained: Buy
Price Target: $80
Current: $76.65
Upside: +4.37%
May 15, 2026
Rated: Hold
Price Target: $28 → $24
Current: $21.52
Upside: +11.52%
May 13, 2026
Maintained: Buy
Price Target: $20
Current: $21.59
Upside: -7.36%
May 6, 2026
Maintained: Hold
Price Target: $73 → $72
Current: $80.70
Upside: -10.78%
May 6, 2026
Maintained: Buy
Price Target: $54 → $50
Current: $39.79
Upside: +25.66%
May 5, 2026
Maintained: Sell
Price Target: $54 → $66
Current: $81.31
Upside: -18.83%
May 5, 2026
Maintained: Buy
Price Target: $17 → $16
Current: $11.66
Upside: +37.22%
May 1, 2026
Maintained: Hold
Price Target: $357 → $361
Current: $319.87
Upside: +12.86%
Apr 30, 2026
Maintained: Hold
Price Target: $147
Current: $110.88
Upside: +32.58%
Apr 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $63.07
Upside: -
Apr 10, 2026
Initiated Coverage: Hold
Price Target: $192 → $167
Current: $158.17
Upside: +5.58%
Apr 9, 2026
Rated: Hold
Price Target: $24 → $17
Current: $24.42
Upside: -30.38%
Feb 10, 2026
Maintained: Sell
Price Target: $93 → $88
Current: $91.12
Upside: -3.42%
May 16, 2016
Upgraded: Hold
Price Target: $39 → $29
Current: $77.86
Upside: n/a
May 16, 2016
Downgraded: Sell
Price Target: $18 → $21
Current: $77.00
Upside: n/a
Nov 15, 2013
Maintained: Sell
Price Target: $103
Current: $108.35
Upside: n/a
Aug 30, 2012
Maintained: Hold
Price Target: $44 → $15
Current: $6.85
Upside: n/a